The effect of different types of medicine information on side effect reporting

Not Applicable

Completed

• Conditions: General medication use; Public Health - Health promotion/education

• Registration Number: ACTRN12620000735954
• Lead Sponsor: Professor Keith Petrie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-07-14
• Study Completion: 2020-10-02
• Last Update Posted: 3 May 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 116

Inclusion Criteria

Participants must be 18 years of age or older, able to read and write in English.

Exclusion Criteria

Participants will be excluded if they are taking any prescription medications, if they have epilepsy, diabetes, any liver or kidney disorders, or any heart problems.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Self-reported side effects measured using a list of 50 symptoms. [20 minutes after taking the placebo tablet and 48 hours after the study session.];Side effect attribution score measure using the Side Effect Attribution Scale (MacKrill et al).[20 minutes after taking the tablet and 48 hours after the study session.]

Secondary Outcome Measures

Name	Time	Method
Change in self-reported mood measured using the PANAS (Watson, Clark, & Tellegen, 1988)[Baseline, 20 minutes after taking placebo tablet, and 48 hours after the study session.];Change in reaction time measured using an online choice reaction task (Deary-Liewald task) powered by PsyToolkit.[Baseline and 20 minutes after taking placebo tablet.];Change in self-reported anxiety measured with the STAI-6 (Marteau & Bekker, 1992)[Baseline, 20 minutes after taking placebo tablet, and 48 hours after the study session.]